Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 18 entries
Sorted by: Best Match Show Resources per page
ASSURE-CSU: a real-world study of burden of disease in patients with symptomatic chronic spontaneous urticaria.

Clinical and translational allergy

Weller K, Maurer M, Grattan C, Nakonechna A, Abuzakouk M, Bérard F, Sussman G, Giménez-Arnau AM, Ortiz de Frutos J, Knulst A, Canonica GW, Hollis K, McBride D, Balp MM.
PMID: 26284152
Clin Transl Allergy. 2015 Aug 17;5:29. doi: 10.1186/s13601-015-0072-9. eCollection 2015.

BACKGROUND: Chronic spontaneous urticaria (CSU) formerly known as chronic idiopathic urticaria (CIU) is a severe and distressing skin condition that remains uncontrolled in approximately one half of patients, despite the use of licensed, recommended doses of modern, second-generation H1-antihistamines....

Cite
Weller K, Maurer M, Grattan C, et al. ASSURE-CSU: a real-world study of burden of disease in patients with symptomatic chronic spontaneous urticaria. Clin Transl Allergy. 2015;5:29doi: 10.1186/s13601-015-0072-9.
Weller, K., Maurer, M., Grattan, C., Nakonechna, A., Abuzakouk, M., Bérard, F., Sussman, G., Giménez-Arnau, A. M., Ortiz de Frutos, J., Knulst, A., Canonica, G. W., Hollis, K., McBride, D., & Balp, M. M. (2015). ASSURE-CSU: a real-world study of burden of disease in patients with symptomatic chronic spontaneous urticaria. Clinical and translational allergy, 529. https://doi.org/10.1186/s13601-015-0072-9
Weller, Karsten, et al. "ASSURE-CSU: a real-world study of burden of disease in patients with symptomatic chronic spontaneous urticaria." Clinical and translational allergy vol. 5 (2015): 29. doi: https://doi.org/10.1186/s13601-015-0072-9
Weller K, Maurer M, Grattan C, Nakonechna A, Abuzakouk M, Bérard F, Sussman G, Giménez-Arnau AM, Ortiz de Frutos J, Knulst A, Canonica GW, Hollis K, McBride D, Balp MM. ASSURE-CSU: a real-world study of burden of disease in patients with symptomatic chronic spontaneous urticaria. Clin Transl Allergy. 2015 Aug 17;5:29. doi: 10.1186/s13601-015-0072-9. eCollection 2015. PMID: 26284152; PMCID: PMC4538755.
Copy Download .nbib Format: NLM
Chronic urticaria patients are interested in apps to monitor their disease activity and control: A UCARE CURICT analysis.

Clinical and translational allergy

Cherrez-Ojeda I, Vanegas E, Cherrez A, Felix M, Weller K, Magerl M, Maurer RR, Mata VL, Kasperska-Zajac A, Sikora A, Fomina D, Kovalkova E, Godse K, Rao ND, Khoshkhui M, Rastgoo S, Criado RFJ, Abuzakouk M, Grandon D, Van Doorn MBA, Rodrigues Valle SO, De Souza Lima EM, Thomsen SF, Ramón GD, Matos Benavides EE, Bauer A, Giménez-Arnau AM, Kocatürk E, Guillet C, Larco JI, Zhao ZT, Makris M, Ritchie C, Xepapadaki P, Ensina LF, Cherrez S, Maurer M.
PMID: 34962721
Clin Transl Allergy. 2021 Dec;11(10):e12089. doi: 10.1002/clt2.12089.

BACKGROUND: Information/communication technologies such as mobile phone applications (apps) would enable chronic urticaria (CU) patients to self-evaluate their disease activity and control. Yet, recently Antó et al (2021) reported a global paucity of such apps for patients with CU....

Cite
Cherrez-Ojeda I, Vanegas E, Cherrez A, et al. Chronic urticaria patients are interested in apps to monitor their disease activity and control: A UCARE CURICT analysis. Clin Transl Allergy. 2021;11(10):e12089doi: 10.1002/clt2.12089.
Cherrez-Ojeda, I., Vanegas, E., Cherrez, A., Felix, M., Weller, K., Magerl, M., Maurer, R. R., Mata, V. L., Kasperska-Zajac, A., Sikora, A., Fomina, D., Kovalkova, E., Godse, K., Rao, N. D., Khoshkhui, M., Rastgoo, S., Criado, R. F. J., Abuzakouk, M., Grandon, D., Van Doorn, M. B. A., Rodrigues Valle, S. O., De Souza Lima, E. M., Thomsen, S. F., Ramón, G. D., Matos Benavides, E. E., Bauer, A., Giménez-Arnau, A. M., Kocatürk, E., Guillet, C., Larco, J. I., Zhao, Z. T., Makris, M., Ritchie, C., Xepapadaki, P., Ensina, L. F., Cherrez, S., & Maurer, M. (2021). Chronic urticaria patients are interested in apps to monitor their disease activity and control: A UCARE CURICT analysis. Clinical and translational allergy, 11(10), e12089. https://doi.org/10.1002/clt2.12089
Cherrez-Ojeda, Ivan, et al. "Chronic urticaria patients are interested in apps to monitor their disease activity and control: A UCARE CURICT analysis." Clinical and translational allergy vol. 11,10 (2021): e12089. doi: https://doi.org/10.1002/clt2.12089
Cherrez-Ojeda I, Vanegas E, Cherrez A, Felix M, Weller K, Magerl M, Maurer RR, Mata VL, Kasperska-Zajac A, Sikora A, Fomina D, Kovalkova E, Godse K, Rao ND, Khoshkhui M, Rastgoo S, Criado RFJ, Abuzakouk M, Grandon D, Van Doorn MBA, Rodrigues Valle SO, De Souza Lima EM, Thomsen SF, Ramón GD, Matos Benavides EE, Bauer A, Giménez-Arnau AM, Kocatürk E, Guillet C, Larco JI, Zhao ZT, Makris M, Ritchie C, Xepapadaki P, Ensina LF, Cherrez S, Maurer M. Chronic urticaria patients are interested in apps to monitor their disease activity and control: A UCARE CURICT analysis. Clin Transl Allergy. 2021 Dec;11(10):e12089. doi: 10.1002/clt2.12089. PMID: 34962721.
Copy Download .nbib Format: NLM
Are the Global Initiative for Asthma (GINA) Guidelines Being Correctly Used to Diagnose Severe Asthma in the UAE?.

Cureus

Abuzakouk M, Jacob S, Ghorab O.
PMID: 33510985
Cureus. 2020 Dec 25;12(12):e12278. doi: 10.7759/cureus.12278.

Objectives We aimed to identify the percentage inaccuracy in classifying asthma severity as severe asthma based on the 2019 Global Initiative for Asthma (GINA) guidelines criteria, at Cleveland Clinic Abu Dhabi, and make recommendations to improve the assessment of...

Cite
Abuzakouk M, Jacob S, Ghorab O. Are the Global Initiative for Asthma (GINA) Guidelines Being Correctly Used to Diagnose Severe Asthma in the UAE?. Cureus. 2020;12(12):e12278doi: 10.7759/cureus.12278.
Abuzakouk, M., Jacob, S., & Ghorab, O. (2020). Are the Global Initiative for Asthma (GINA) Guidelines Being Correctly Used to Diagnose Severe Asthma in the UAE?. Cureus, 12(12), e12278. https://doi.org/10.7759/cureus.12278
Abuzakouk, Mohamed, et al. "Are the Global Initiative for Asthma (GINA) Guidelines Being Correctly Used to Diagnose Severe Asthma in the UAE?." Cureus vol. 12,12 (2020): e12278. doi: https://doi.org/10.7759/cureus.12278
Abuzakouk M, Jacob S, Ghorab O. Are the Global Initiative for Asthma (GINA) Guidelines Being Correctly Used to Diagnose Severe Asthma in the UAE?. Cureus. 2020 Dec 25;12(12):e12278. doi: 10.7759/cureus.12278. PMID: 33510985; PMCID: PMC7828644.
Copy Download .nbib Format: NLM
How are patients with chronic urticaria interested in using information and communication technologies to guide their healthcare? A UCARE study.

The World Allergy Organization journal

Cherrez-Ojeda I, Vanegas E, Cherrez A, Felix M, Weller K, Magerl M, Maurer RR, Mata VL, Kasperska-Zajac A, Sikora A, Fomina D, Kovalkova E, Godse K, Rao ND, Khoshkhui M, Rastgoo S, Criado RF, Abuzakouk M, Grandon D, Van Doorn MBA, Oliveira Rodrigues Valle S, De Souza Lima EM, Thomsen SF, Ramón GD, Matos Benavides EE, Bauer A, Giménez-Arnau AM, Kocatürk E, Guillet C, Larco JI, Zhao ZT, Makris M, Ritchie C, Xepapadaki P, Ensina LF, Cherrez S, Maurer M.
PMID: 34141048
World Allergy Organ J. 2021 Jun 04;14(6):100542. doi: 10.1016/j.waojou.2021.100542. eCollection 2021 Jun.

BACKGROUND: Patients with chronic urticaria (CU) are increasingly using information and communication technologies (ICTs) to manage their health. What CU patients expect from ICTs and which ICTs they prefer remains unknown. We assessed why CU patients use ICTs, which...

Cite
Cherrez-Ojeda I, Vanegas E, Cherrez A, et al. How are patients with chronic urticaria interested in using information and communication technologies to guide their healthcare? A UCARE study. World Allergy Organ J. 2021;14(6):100542doi: 10.1016/j.waojou.2021.100542.
Cherrez-Ojeda, I., Vanegas, E., Cherrez, A., Felix, M., Weller, K., Magerl, M., Maurer, R. R., Mata, V. L., Kasperska-Zajac, A., Sikora, A., Fomina, D., Kovalkova, E., Godse, K., Rao, N. D., Khoshkhui, M., Rastgoo, S., Criado, R. F., Abuzakouk, M., Grandon, D., Van Doorn, M. B. A., Oliveira Rodrigues Valle, S., De Souza Lima, E. M., Thomsen, S. F., Ramón, G. D., Matos Benavides, E. E., Bauer, A., Giménez-Arnau, A. M., Kocatürk, E., Guillet, C., Larco, J. I., Zhao, Z. T., Makris, M., Ritchie, C., Xepapadaki, P., Ensina, L. F., Cherrez, S., & Maurer, M. (2021). How are patients with chronic urticaria interested in using information and communication technologies to guide their healthcare? A UCARE study. The World Allergy Organization journal, 14(6), 100542. https://doi.org/10.1016/j.waojou.2021.100542
Cherrez-Ojeda, Ivan, et al. "How are patients with chronic urticaria interested in using information and communication technologies to guide their healthcare? A UCARE study." The World Allergy Organization journal vol. 14,6 (2021): 100542. doi: https://doi.org/10.1016/j.waojou.2021.100542
Cherrez-Ojeda I, Vanegas E, Cherrez A, Felix M, Weller K, Magerl M, Maurer RR, Mata VL, Kasperska-Zajac A, Sikora A, Fomina D, Kovalkova E, Godse K, Rao ND, Khoshkhui M, Rastgoo S, Criado RF, Abuzakouk M, Grandon D, Van Doorn MBA, Oliveira Rodrigues Valle S, De Souza Lima EM, Thomsen SF, Ramón GD, Matos Benavides EE, Bauer A, Giménez-Arnau AM, Kocatürk E, Guillet C, Larco JI, Zhao ZT, Makris M, Ritchie C, Xepapadaki P, Ensina LF, Cherrez S, Maurer M. How are patients with chronic urticaria interested in using information and communication technologies to guide their healthcare? A UCARE study. World Allergy Organ J. 2021 Jun 04;14(6):100542. doi: 10.1016/j.waojou.2021.100542. eCollection 2021 Jun. PMID: 34141048; PMCID: PMC8190491.
Copy Download .nbib Format: NLM
Challenges in Establishing a Coronavirus Disease 2019 (COVID-19) Convalescent Plasma Donation Program in a Multicultural Environment.

Archives of pathology & laboratory medicine

Algora M, Mehmood T, Madison DL, AlAmeri J, Abuzakouk M, Tagamtam M, Acena L, Totaan G, Grabski G, Oumeziane N, Rajani P, Taylor L, Guzman J, AbdelWareth LO.
PMID: 34407176
Arch Pathol Lab Med. 2021 Dec 01;145(12):1479-1484. doi: 10.5858/arpa.2021-0198-SA.

CONTEXT.—: In the face of the coronavirus disease 2019 (COVID-19) pandemic response, it was worthwhile to test the safety and efficacy of COVID-19 convalescent plasma (CCP) transfusion.OBJECTIVE.—: To establish a CCP donation program based on the availability of recovered...

Cite
Algora M, Mehmood T, Madison DL, et al. Challenges in Establishing a Coronavirus Disease 2019 (COVID-19) Convalescent Plasma Donation Program in a Multicultural Environment. Arch Pathol Lab Med. 2021;145(12):1479-1484doi: 10.5858/arpa.2021-0198-SA.
Algora, M., Mehmood, T., Madison, D. L., AlAmeri, J., Abuzakouk, M., Tagamtam, M., Acena, L., Totaan, G., Grabski, G., Oumeziane, N., Rajani, P., Taylor, L., Guzman, J., & AbdelWareth, L. O. (2021). Challenges in Establishing a Coronavirus Disease 2019 (COVID-19) Convalescent Plasma Donation Program in a Multicultural Environment. Archives of pathology & laboratory medicine, 145(12), 1479-1484. https://doi.org/10.5858/arpa.2021-0198-SA
Algora, Manuel, et al. "Challenges in Establishing a Coronavirus Disease 2019 (COVID-19) Convalescent Plasma Donation Program in a Multicultural Environment." Archives of pathology & laboratory medicine vol. 145,12 (2021): 1479-1484. doi: https://doi.org/10.5858/arpa.2021-0198-SA
Algora M, Mehmood T, Madison DL, AlAmeri J, Abuzakouk M, Tagamtam M, Acena L, Totaan G, Grabski G, Oumeziane N, Rajani P, Taylor L, Guzman J, AbdelWareth LO. Challenges in Establishing a Coronavirus Disease 2019 (COVID-19) Convalescent Plasma Donation Program in a Multicultural Environment. Arch Pathol Lab Med. 2021 Dec 01;145(12):1479-1484. doi: 10.5858/arpa.2021-0198-SA. PMID: 34407176.
Copy Download .nbib Format: NLM
Chronic urticaria patients are interested in apps to monitor their disease activity and control: A UCARE CURICT analysis.

Clinical and translational allergy

Cherrez-Ojeda I, Vanegas E, Cherrez A, Felix M, Weller K, Magerl M, Maurer RR, Mata VL, Kasperska-Zajac A, Sikora A, Fomina D, Kovalkova E, Godse K, Rao ND, Khoshkhui M, Rastgoo S, Criado RFJ, Abuzakouk M, Grandon D, Van Doorn MBA, Rodrigues Valle SO, De Souza Lima EM, Thomsen SF, Ramón GD, Matos Benavides EE, Bauer A, Giménez-Arnau AM, Kocatürk E, Guillet C, Larco JI, Zhao ZT, Makris M, Ritchie C, Xepapadaki P, Ensina LF, Cherrez S, Maurer M.
PMID: 34962721
Clin Transl Allergy. 2021 Dec;11(10):e12089. doi: 10.1002/clt2.12089.

BACKGROUND: Information/communication technologies such as mobile phone applications (apps) would enable chronic urticaria (CU) patients to self-evaluate their disease activity and control. Yet, recently Antó et al (2021) reported a global paucity of such apps for patients with CU....

Cite
Cherrez-Ojeda I, Vanegas E, Cherrez A, et al. Chronic urticaria patients are interested in apps to monitor their disease activity and control: A UCARE CURICT analysis. Clin Transl Allergy. 2021;11(10):e12089doi: 10.1002/clt2.12089.
Cherrez-Ojeda, I., Vanegas, E., Cherrez, A., Felix, M., Weller, K., Magerl, M., Maurer, R. R., Mata, V. L., Kasperska-Zajac, A., Sikora, A., Fomina, D., Kovalkova, E., Godse, K., Rao, N. D., Khoshkhui, M., Rastgoo, S., Criado, R. F. J., Abuzakouk, M., Grandon, D., Van Doorn, M. B. A., Rodrigues Valle, S. O., De Souza Lima, E. M., Thomsen, S. F., Ramón, G. D., Matos Benavides, E. E., Bauer, A., Giménez-Arnau, A. M., Kocatürk, E., Guillet, C., Larco, J. I., Zhao, Z. T., Makris, M., Ritchie, C., Xepapadaki, P., Ensina, L. F., Cherrez, S., & Maurer, M. (2021). Chronic urticaria patients are interested in apps to monitor their disease activity and control: A UCARE CURICT analysis. Clinical and translational allergy, 11(10), e12089. https://doi.org/10.1002/clt2.12089
Cherrez-Ojeda, Ivan, et al. "Chronic urticaria patients are interested in apps to monitor their disease activity and control: A UCARE CURICT analysis." Clinical and translational allergy vol. 11,10 (2021): e12089. doi: https://doi.org/10.1002/clt2.12089
Cherrez-Ojeda I, Vanegas E, Cherrez A, Felix M, Weller K, Magerl M, Maurer RR, Mata VL, Kasperska-Zajac A, Sikora A, Fomina D, Kovalkova E, Godse K, Rao ND, Khoshkhui M, Rastgoo S, Criado RFJ, Abuzakouk M, Grandon D, Van Doorn MBA, Rodrigues Valle SO, De Souza Lima EM, Thomsen SF, Ramón GD, Matos Benavides EE, Bauer A, Giménez-Arnau AM, Kocatürk E, Guillet C, Larco JI, Zhao ZT, Makris M, Ritchie C, Xepapadaki P, Ensina LF, Cherrez S, Maurer M. Chronic urticaria patients are interested in apps to monitor their disease activity and control: A UCARE CURICT analysis. Clin Transl Allergy. 2021 Dec;11(10):e12089. doi: 10.1002/clt2.12089. PMID: 34962721; PMCID: PMC8684305.
Copy Download .nbib Format: NLM
Expert Opinion on Biological Treatment of Chronic Rhinosinusitis with Nasal Polyps in the Gulf Region.

Journal of asthma and allergy

Al-Ahmad M, Alsaleh S, Al-Reefy H, Al Abduwani J, Nasr I, Al Abri R, Alamadi AMH, Fraihat AA, Alterki A, Abuzakouk M, Marglani O, Rand HA.
PMID: 35018101
J Asthma Allergy. 2022 Jan 04;15:1-12. doi: 10.2147/JAA.S321017. eCollection 2022.

Chronic rhinosinusitis (CRS) is defined as the inflammation of nose and paranasal sinuses, affecting the patients' quality of life and productivity. Chronic rhinosinusitis with nasal polyps (CRSwNP) is a principal clinical entity confirmed by the existence of chronic sinonasal...

Cite
Al-Ahmad M, Alsaleh S, Al-Reefy H, et al. Expert Opinion on Biological Treatment of Chronic Rhinosinusitis with Nasal Polyps in the Gulf Region. J Asthma Allergy. 2022;15:1-12doi: 10.2147/JAA.S321017.
Al-Ahmad, M., Alsaleh, S., Al-Reefy, H., Al Abduwani, J., Nasr, I., Al Abri, R., Alamadi, A. M. H., Fraihat, A. A., Alterki, A., Abuzakouk, M., Marglani, O., & Rand, H. A. (2022). Expert Opinion on Biological Treatment of Chronic Rhinosinusitis with Nasal Polyps in the Gulf Region. Journal of asthma and allergy, 151-12. https://doi.org/10.2147/JAA.S321017
Al-Ahmad, Mona, et al. "Expert Opinion on Biological Treatment of Chronic Rhinosinusitis with Nasal Polyps in the Gulf Region." Journal of asthma and allergy vol. 15 (2022): 1-12. doi: https://doi.org/10.2147/JAA.S321017
Al-Ahmad M, Alsaleh S, Al-Reefy H, Al Abduwani J, Nasr I, Al Abri R, Alamadi AMH, Fraihat AA, Alterki A, Abuzakouk M, Marglani O, Rand HA. Expert Opinion on Biological Treatment of Chronic Rhinosinusitis with Nasal Polyps in the Gulf Region. J Asthma Allergy. 2022 Jan 04;15:1-12. doi: 10.2147/JAA.S321017. eCollection 2022. PMID: 35018101; PMCID: PMC8742580.
Copy Download .nbib Format: NLM
Convalescent Plasma Efficacy in Life-Threatening COVID-19 Patients Admitted to the ICU: A Retrospective Cohort Study.

Journal of clinical medicine

Abuzakouk M, Saleh K, Algora M, Nusair A, Alameri J, Alshehhi F, Alkhaja S, Badr M, Abdallah K, De Oliveira B, Nadeem A, Varghese Y, Munde D, Salam S, Abduljawad B, Elkambergy H, Wahla A, Taha A, Dibu J, Bayrlee A, Hamed F, AbdelWareth L, Rahman N, Guzman J, Mallat J.
PMID: 34068847
J Clin Med. 2021 May 14;10(10). doi: 10.3390/jcm10102113.

(1) Background: There are limited data regarding the efficacy of convalescent plasma (CP) in critically ill patients admitted to the intensive care unit (ICU) due to coronavirus disease 2019 (COVID-19). We aimed to determine whether CP is associated with...

Cite
Abuzakouk M, Saleh K, Algora M, et al. Convalescent Plasma Efficacy in Life-Threatening COVID-19 Patients Admitted to the ICU: A Retrospective Cohort Study. J Clin Med. 2021;10(10)doi: 10.3390/jcm10102113.
Abuzakouk, M., Saleh, K., Algora, M., Nusair, A., Alameri, J., Alshehhi, F., Alkhaja, S., Badr, M., Abdallah, K., De Oliveira, B., Nadeem, A., Varghese, Y., Munde, D., Salam, S., Abduljawad, B., Elkambergy, H., Wahla, A., Taha, A., Dibu, J., Bayrlee, A., Hamed, F., AbdelWareth, L., Rahman, N., Guzman, J., & Mallat, J. (2021). Convalescent Plasma Efficacy in Life-Threatening COVID-19 Patients Admitted to the ICU: A Retrospective Cohort Study. Journal of clinical medicine, 10(10), . https://doi.org/10.3390/jcm10102113
Abuzakouk, Mohamed, et al. "Convalescent Plasma Efficacy in Life-Threatening COVID-19 Patients Admitted to the ICU: A Retrospective Cohort Study." Journal of clinical medicine vol. 10,10 (2021). doi: https://doi.org/10.3390/jcm10102113
Abuzakouk M, Saleh K, Algora M, Nusair A, Alameri J, Alshehhi F, Alkhaja S, Badr M, Abdallah K, De Oliveira B, Nadeem A, Varghese Y, Munde D, Salam S, Abduljawad B, Elkambergy H, Wahla A, Taha A, Dibu J, Bayrlee A, Hamed F, AbdelWareth L, Rahman N, Guzman J, Mallat J. Convalescent Plasma Efficacy in Life-Threatening COVID-19 Patients Admitted to the ICU: A Retrospective Cohort Study. J Clin Med. 2021 May 14;10(10). doi: 10.3390/jcm10102113. PMID: 34068847; PMCID: PMC8153619.
Copy Download .nbib Format: NLM
Hereditary Angioedema Type II: First Presentation in Adulthood with Recurrent Severe Abdominal Pain.

Case reports in immunology

Abuzakouk M, AlMahmeed N, Memisoglu E, McManus M, Alrakawi A.
PMID: 30510820
Case Reports Immunol. 2018 Oct 29;2018:7435870. doi: 10.1155/2018/7435870. eCollection 2018.

A 27-year-old Emirate man presented to Cleveland Clinic Abu Dhabi emergency department with a 4 year history of recurrent episodes of severe swellings affecting different parts of his body. He used to get 2 swelling episodes every week affecting...

Cite
Abuzakouk M, AlMahmeed N, Memisoglu E, et al. Hereditary Angioedema Type II: First Presentation in Adulthood with Recurrent Severe Abdominal Pain. Case Reports Immunol. 2018;2018:7435870doi: 10.1155/2018/7435870.
Abuzakouk, M., AlMahmeed, N., Memisoglu, E., McManus, M., & Alrakawi, A. (2018). Hereditary Angioedema Type II: First Presentation in Adulthood with Recurrent Severe Abdominal Pain. Case reports in immunology, 20187435870. https://doi.org/10.1155/2018/7435870
Abuzakouk, Mohamed, et al. "Hereditary Angioedema Type II: First Presentation in Adulthood with Recurrent Severe Abdominal Pain." Case reports in immunology vol. 2018 (2018): 7435870. doi: https://doi.org/10.1155/2018/7435870
Abuzakouk M, AlMahmeed N, Memisoglu E, McManus M, Alrakawi A. Hereditary Angioedema Type II: First Presentation in Adulthood with Recurrent Severe Abdominal Pain. Case Reports Immunol. 2018 Oct 29;2018:7435870. doi: 10.1155/2018/7435870. eCollection 2018. PMID: 30510820; PMCID: PMC6231379.
Copy Download .nbib Format: NLM
Demographic and Clinical Patterns of Rheumatoid Arthritis in an Emirati Cohort from United Arab Emirates.

International journal of rheumatology

Namas R, Joshi A, Ali Z, Al Saleh J, Abuzakouk M.
PMID: 31662761
Int J Rheumatol. 2019 Sep 25;2019:3057578. doi: 10.1155/2019/3057578. eCollection 2019.

This retrospective cohort study aimed to assess the demographic and clinical characteristics of rheumatoid arthritis (RA) in Emirati patients attending Cleveland Clinic Abu Dhabi, a large tertiary center in the Middle East. In this study, 414 Emirati patients with...

Cite
Namas R, Joshi A, Ali Z, et al. Demographic and Clinical Patterns of Rheumatoid Arthritis in an Emirati Cohort from United Arab Emirates. Int J Rheumatol. 2019;2019:3057578doi: 10.1155/2019/3057578.
Namas, R., Joshi, A., Ali, Z., Al Saleh, J., & Abuzakouk, M. (2019). Demographic and Clinical Patterns of Rheumatoid Arthritis in an Emirati Cohort from United Arab Emirates. International journal of rheumatology, 20193057578. https://doi.org/10.1155/2019/3057578
Namas, Rajaie, et al. "Demographic and Clinical Patterns of Rheumatoid Arthritis in an Emirati Cohort from United Arab Emirates." International journal of rheumatology vol. 2019 (2019): 3057578. doi: https://doi.org/10.1155/2019/3057578
Namas R, Joshi A, Ali Z, Al Saleh J, Abuzakouk M. Demographic and Clinical Patterns of Rheumatoid Arthritis in an Emirati Cohort from United Arab Emirates. Int J Rheumatol. 2019 Sep 25;2019:3057578. doi: 10.1155/2019/3057578. eCollection 2019. PMID: 31662761; PMCID: PMC6778867.
Copy Download .nbib Format: NLM
Correlation between Reduced FEF25-75% and a Positive Methacholine Challenge Test in Adults with Nonobstructive Baseline Spirometry.

Pulmonary medicine

Shafiq I, Uzbeck MH, Zoumot Z, Abuzakouk M, Parappurath N, Wahla AS.
PMID: 35003806
Pulm Med. 2021 Dec 29;2021:6959322. doi: 10.1155/2021/6959322. eCollection 2021.

OBJECTIVE: To clarify whether in adults with a nonobstructive spirometry a reduced FEF25-75% is associated with a positive methacholine challenge test (MCT).METHODS: Data was collected for all the patients who had a MCT done between April 2014 and January...

Cite
Shafiq I, Uzbeck MH, Zoumot Z, et al. Correlation between Reduced FEF25-75% and a Positive Methacholine Challenge Test in Adults with Nonobstructive Baseline Spirometry. Pulm Med. 2021;2021:6959322doi: 10.1155/2021/6959322.
Shafiq, I., Uzbeck, M. H., Zoumot, Z., Abuzakouk, M., Parappurath, N., & Wahla, A. S. (2021). Correlation between Reduced FEF25-75% and a Positive Methacholine Challenge Test in Adults with Nonobstructive Baseline Spirometry. Pulmonary medicine, 20216959322. https://doi.org/10.1155/2021/6959322
Shafiq, Irfan, et al. "Correlation between Reduced FEF25-75% and a Positive Methacholine Challenge Test in Adults with Nonobstructive Baseline Spirometry." Pulmonary medicine vol. 2021 (2021): 6959322. doi: https://doi.org/10.1155/2021/6959322
Shafiq I, Uzbeck MH, Zoumot Z, Abuzakouk M, Parappurath N, Wahla AS. Correlation between Reduced FEF25-75% and a Positive Methacholine Challenge Test in Adults with Nonobstructive Baseline Spirometry. Pulm Med. 2021 Dec 29;2021:6959322. doi: 10.1155/2021/6959322. eCollection 2021. PMID: 35003806; PMCID: PMC8731260.
Copy Download .nbib Format: NLM
Efficacy and Safety of Biologic Agents in Chronic Urticaria, Asthma and Atopic Dermatitis - A Real-life Experience.

The open respiratory medicine journal

Abuzakouk M, Ghorab OKHA, Wahla AS, Zoumot Z, Nasir M, Grandon D, Uzbeck MH, Salvo F, Shafiq I.
PMID: 33717370
Open Respir Med J. 2020 Dec 31;14:99-106. doi: 10.2174/1874306402014010099. eCollection 2020.

INTRODUCTION: Several biologic agents have been approved for the treatment of asthma, chronic urticaria and atopic dermatitis. These therapeutic agents are especially useful for patients with severe or refractory symptoms. We present the real-life experience of four of the...

Cite
Abuzakouk M, Ghorab OKHA, Wahla AS, et al. Efficacy and Safety of Biologic Agents in Chronic Urticaria, Asthma and Atopic Dermatitis - A Real-life Experience. Open Respir Med J. 2020;14:99-106doi: 10.2174/1874306402014010099.
Abuzakouk, M., Ghorab, O. K. H. A., Wahla, A. S., Zoumot, Z., Nasir, M., Grandon, D., Uzbeck, M. H., Salvo, F., & Shafiq, I. (2020). Efficacy and Safety of Biologic Agents in Chronic Urticaria, Asthma and Atopic Dermatitis - A Real-life Experience. The open respiratory medicine journal, 1499-106. https://doi.org/10.2174/1874306402014010099
Abuzakouk, Mohamed, et al. "Efficacy and Safety of Biologic Agents in Chronic Urticaria, Asthma and Atopic Dermatitis - A Real-life Experience." The open respiratory medicine journal vol. 14 (2020): 99-106. doi: https://doi.org/10.2174/1874306402014010099
Abuzakouk M, Ghorab OKHA, Wahla AS, Zoumot Z, Nasir M, Grandon D, Uzbeck MH, Salvo F, Shafiq I. Efficacy and Safety of Biologic Agents in Chronic Urticaria, Asthma and Atopic Dermatitis - A Real-life Experience. Open Respir Med J. 2020 Dec 31;14:99-106. doi: 10.2174/1874306402014010099. eCollection 2020. PMID: 33717370; PMCID: PMC7931148.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 18 entries